An independent committee advising the FDA voted against Pfizer’s COVID-19 vaccine booster shot.
Federal health officials on Friday announced a $2.1 billion investment to strengthen infection prevention and control measures against COVID-19 and other infectious diseases across the public healthcare sector.
Moderna has begun submitting data on its COVID-19 booster vaccine to the Food and Drug Administration for review.
Moderna has completed a submission filing for full FDA approval of its COVID-19 vaccine in individuals 18 and up.
Johnson & Johnson announced longstanding CEO Alex Gorsky will transition out of the role, with Joaquin Duato set to lead the health care company effective Jan. 3.
The Food and Drug Administration (FDA) on Monday granted full approval to Pfizer's COVID-19 vaccine for individuals 16 years and older.
President Biden leaned into the new FDA licensure, or full approval, of the Pfizer-BioNTech COVID-19 vaccine on Monday, encouraging businesses to require vaccinations among employees.
Federal regulators issued full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday following rigorous review and independent analyses of data submitted through a biologics license application.
Maryland-based biotech Novavax announced a delay in plans to file for U.S. FDA authorization of its COVID-19 vaccine.